Sponsor:
Jeremy Koppel
Code:
NCT06336382
Conditions
Late Onset Schizophrenia
Delusional Disorder (Late Onset)
Eligibility Criteria
Sex: All
Age: 65 - 70+
Healthy Volunteers: Not accepted
Interventions
Tau PET imaging scan
Brief summary:
Conditions
Late Onset Schizophrenia
Delusional Disorder (Late Onset)
Study ID
NCT06336382
Start date
Feb 16, 2024
Status verified date
Sep, 2025
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 65 - 70+
Healthy Volunteers: Not accepted
Enrollment
16 participants
Anticipated
Interventions
Tau PET imaging scan
Primary outcome measure
Central contacts
Locations
The Feinstein Institutes for Medical Research
Recruiting
Manhasset, New York, United States, 11030
Contacts
Sponsor
Jeremy Koppel
Last update posted
Sep 29, 2025
Last verified
Sep, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Jeremy Koppel on 2025-09-29.